日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.

对轻度阿尔茨海默病 1 期衰老细胞清除试验中探索性体液生物标志物的评估

Garbarino Valentina R, Palavicini Juan Pablo, Melendez Justin, Barthelemy Nicolas R, He Yingxin, Kautz Tiffany F, Lopez-Cruzan Marisa, Mathews Julia J, Xu Peng, Zhang Bin, Saliba Afaf, Ragi Nagarjunachary, Sharma Kumar, Mason Dallin, Johnson Samuel, Hendrix Suzanne, Craft Suzanne, Petersen Ronald C, Espindola-Netto Jair Machado, Xue Ailing, Tchkonia Tamara, Kirkland James L, Salardini Arash, Musi Nicolas, Bateman Randall J, Gonzales Mitzi M, Orr Miranda E

Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozin

更正:用硫代硫酸钠、16-羟基雌三醇和延迟起始卡格列净治疗的雄性UM-HET3小鼠的寿命效应

Miller, Richard A; Harrison, David E; Cortopassi, Gino A; Dehghan, Ishmael; Fernandez, Elizabeth; Garratt, Michael; Geisler, John G; Ginsburg, Brett C; Han, Melissa L; Jiang, Nisi; Kaczorowski, Catherine C; Kumar, Navasuja; Leiser, Scott F; Lopez-Cruzan, Marisa; Milne, Ginger; Mitchell, James R; Nelson, James F; Reifsnyder, Peter C; Salmon, Adam B; Xu, Ziying; Korstanje, Ron; Rosenthal, Nadia; Strong, Randy

Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozin

更正:用硫代硫酸钠、16-羟基雌二醇和延迟起始卡格列净治疗的雄性UM-HET3小鼠的寿命效应

Miller, Richard A; Harrison, David E; Cortopassi, Gino A; Dehghan, Ishmael; Fernandez, Elizabeth; Garratt, Michael; Geisler, John G; Ginsburg, Brett C; Han, Melissa L; Kaczorowski, Catherine C; Kumar, Navasuja; Leiser, Scott F; Lopez-Cruzan, Marisa; Milne, Ginger; Mitchell, James R; Nelson, James F; Reifsnyder, Peter C; Salmon, Adam B; Korstanje, Ron; Rosenthal, Nadia; Strong, Randy

A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)

一项评估抗逆转录病毒疗法对阿尔茨海默病疗效的 IIa 期临床试验 (ART-AD)

Sullivan, A Campbell; Zuniga, Gabrielle; Ramirez, Paulino; Fernandez, Roman; Wang, Chen-Pin; Li, Ji; Davila, Lisa; Pelton, Kristine; Gomez, Sandra; Sohn, Claira; Gonzalez, Elias; Lopez-Cruzan, Marisa; Gonzalez, David A; Parker, Alicia; Zilli, Eduardo; de Erausquin, Gabriel A; Seshadri, Sudha; Espinoza, Sara; Musi, Nicolas; Frost, Bess

Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial

雷帕霉素治疗阿尔茨海默病及相关痴呆症:一项初步的1期临床试验

Gonzales, Mitzi M; Garbarino, Valentina R; Kautz, Tiffany F; Song, Xuemei; Lopez-Cruzan, Marisa; Linehan, Leslie; Van Skike, Candice E; De Erausquin, Gabriel A; Galvan, Veronica; Orr, Miranda E; Musi, Nicolas; He, Yingxin; Bateman, Randall J; Wang, Chen-Pin; Seshadri, Sudha; Kraig, Ellen; Kellogg, Dean Jr

Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin

用硫代硫酸钠、16-羟基雌三醇和延迟起始卡格列净治疗的雄性UM-HET3小鼠的寿命效应

Miller, Richard A; Harrison, David E; Cortopassi, Gino A; Dehghan, Ishmael; Fernandez, Elizabeth; Garratt, Michael; Geisler, John G; Ginsburg, Brett C; Han, Melissa L; Kaczorowski, Catherine C; Kumar, Navasuja; Leiser, Scott F; Lopez-Cruzan, Marisa; Milne, Ginger; Mitchell, James R; Nelson, James F; Reifsnyder, Peter C; Salmon, Adam B; Korstanje, Ron; Rosenthal, Nadia; Strong, Randy

Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used

虾青素和美克洛嗪可延长 UM-HET3 雄性小鼠的寿命;在所用剂量和给药方案下,非瑟酮、SG1002(硫化氢供体)、富马酸二甲酯、霉酚酸和 4-苯基丁酸不会显著影响任何性别的寿命

David E Harrison #, Randy Strong #, Peter Reifsnyder, Nadia Rosenthal, Ron Korstanje, Elizabeth Fernandez, Kevin Flurkey, Brett C Ginsburg, Meredith D Murrell, Martin A Javors, Marisa Lopez-Cruzan, James F Nelson, Bradley J Willcox, Richard Allsopp, David M Watumull, David G Watumull, Gino Cortopass

Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's Disease

轻度阿尔茨海默病 1 期 Senolytic 试验的探索性液体生物标志物结果评估

Valentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, Nicolas Barthelemy, Yingxin He, Tiffany F Kautz, Marisa Lopez-Cruzan, Julia J Mathews, Peng Xu, Bin Zhan, Afaf Saliba, Nagarjunachary Ragi, Kumar Sharma, Suzanne Craft, Ronald C Petersen, Jair Machado Espindola-Netto, Ailing Xue, Tamara

A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD)

一项旨在探讨抗逆转录病毒疗法治疗阿尔茨海默病(ART-AD)的安全性和可行性的试点研究

A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, Roman Fernandez, Chen-Pin Wang, Ji Li, Lisa Davila, Kristine Pelton, Sandra Gomez, Claira Sohn, Elias Gonzalez, Marisa Lopez-Cruzan, David A Gonzalez, Alicia Parker, Eduardo Zilli, Gabriel A de Erausquin, Sudha Seshadri, Sara Espinoza, Nicolas

Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial

轻度阿尔茨海默病的抗衰老疗法:第一阶段可行性试验

Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia J Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudh